Cart
×
Ask the Experts Video Series Webinars
CureDuchenne cornered the best and brightest to gather relevant information for people living with Duchenne. Tiffany Cook asks the questions you’ve been thinking – from experts in their field who […]
CureDuchenne Launches Virtual Napa Wine Series to Connect Communities with Napa Valley Vintners
Newport Beach, CA, May 7, 2020 – CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, is announcing the Virtual Napa Wine Series […]
Información y recursos de Duchenne sobre COVID-19
Descripción: Un evento virtual de dos horas centrado en la información sobre COVID-19 y los recursos en el hogar para las personas que viven con Duchenne. Seminario web de Zoom: Abierto al público, dirigido a la comunidad de Duchenne de habla hispana Panelistas: Dr. […]
Italfarmaco Provides Update on Advanced-Stage Clinical Development Program with Givinostat in Duchenne Muscular Dystrophy
— The Interim data from EPYDIS Phase 3 trial shows that the trial is NOT FUTILE and the Independent Data Monitoring Committee recommends trial continuation — — Blinded re-estimation of […]
Myosana Therapeutics, Inc. Raises Up To $1M from CureDuchenne Ventures
Newport Beach, CA & Seattle, WA, April 22, 2020: Myosana Therapeutics, Inc., a new biotech company developing novel platform technology for non-viral gene delivery, raised up to $1M in seed […]
CureDuchenne Ventures’ latest investment in Myosana Therapeutics
CureDuchenne Ventures is happy to announce its latest investment in Myosana Therapeutics, a new biotech company based in Seattle, WA. Myosana is aiming to develop next-generation gene therapy for Duchenne muscular dystrophy and other neuromuscular […]
Letter to the Community – Myosana Therapeutics
Dear Duchenne Community, I’m truly thrilled about our investment in a new biotech company called Myosana Therapeutics. Myosana aims to develop next-generation gene therapy for Duchenne muscular dystrophy and neuromuscular diseases. Because of this investment, the team is now positioned to conduct […]
We remain strong, stable and committed to you
Dear Duchenne Community, We are proud that, through these difficult times, CureDuchenne is continuing to invest in research, to expand our programs and offer services to the Duchenne Community. All of us are feeling the personal, emotional and financial toll […]